MicroBiome Bank

26/10/2025

Microbiota Manipulation Guide

I. Introduction

1. Building a New Life, One Microbe at a Time - Why this Handbook is Essential
For centuries, microorganisms were viewed through a lens of fear and hostility. From Leeuwenhoek’s first glimpses of “animalcules” to Pasteur’s germ theory, our relationship with microbes has oscillated between fascination and warfare. The 20th century, with its obsession for sterility, antibiotics and disinfectants, nearly erased the understanding that microbes are not merely enemies but essential allies in human health.

Today, a more measured scientific view recognises the human body as an ecosystem in which microbes contribute to digestion, immunity and metabolism; this handbook applies that view in practical, clinical contexts [6].

Science redefines this relationship. We now recognize that the human body is a superorganism, an intricate ecosystem of human cells and trillions of microorganisms -bacteria, viruses, fungi, and archaea – that co-regulate our digestion, immunity, metabolism, even our mood and behavior. This community is called the microbiota, while the genetic library they carry is known as the microbiome.

At MicroBiome Bank, our mission is to help restore this fragile balance, particularly for those whose microbial ecosystems have been devastated – by infections, antibiotics, lifestyle, or environmental exposures. Since 2016, we have specialized in lyophilized (freeze-dried) human microbiota transfers, supporting different trials, sports medicine, and hospital treatments across Europe.

It is important to emphasise that this handbook is not designed as promotional material but as a practical clinical and educational tool. Its aim is to bring together established microbiological knowledge, current therapeutic experience and realistic patient pathways.

2. Dysbiosis – The Invisible Root of Many Diseases
A disrupted microbiota, known as dysbiosis, is not a disease in itself but an ecological imbalance. Dysbiosis can manifest in three primary ways:
- Loss of microbial diversity, reducing resilience.
- Overgrowth of opportunistic species (e.g., Clostridioides difficile).
- Functional dysregulation, where microbes behave abnormally even if present.

While C. difficile infections are often cited as the hallmark of severe dysbiosis, many chronic illnesses share this ecological root cause – Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), metabolic syndromes, neuropsychiatric disorders, allergies, and autoimmune diseases. These conditions are not isolated malfunctions of organs but symptoms of a malfunctioning ecosystem.

It may be useful to introduce the opposite concept: eubiosis. In this balanced state the intestinal community maintains functional diversity, immune tolerance, and metabolic stability in a dynamic manner. In practice dysbiosis represents a deviation from this baseline rather than a distinct pathological entity. [5]

In this context, treating infections with antibiotics becomes a paradox – eliminating pathogens while further damaging the microbial community that should keep them in check. This is why Clostridioides difficile relapses are so common after antibiotic treatments [1]. The key is not to eliminate a single bacterium but to restore the entire microbial balance.

3. FMT Capsules – Planting a New Microbial Ecosystem
Our FMT capsule formulations, like HospBiome, DiffBiome and TransferBiome are designed to reintroduce diverse, robust microbial communities into a damaged gut ecosystem. These capsules are prepared with strict microbiological protocols, ensuring both safety and efficacy.

The therapeutic effect of FMT is not limited to bacterial reintroduction. A transplant also carries metabolites, bacteriophages, i.e. a complete microbial network that influences short-chain fatty acid (SCFA) production, mucosal immunity and epithelial barrier function. In particular, butyrate-producing strains play a central role in regulating local and systemic inflammation. [2], [5]

But a successful transplant is not just about delivering microbes. It’s about creating a favorable environment where they can establish, multiply, and function harmoniously. This is why the Symptom Importance Scale (SIS) for C. difficile patients and the Disbiosys Scale for people suffering from various gut issues were developed – to help healthcare providers dynamically adjust dosage and intensity based on the severity of dysbiosis, infection burden, and patient-specific factors until more sophisticated and well established scoring systems become available.

At MicroBiome Bank, we don’t just provide capsules; we offer clinical support frameworks, enabling hospitals and physicians to deliver microbiota transfer therapies within 72 hours across Europe. For clinicians, this means practical availability of a therapy that in randomised trials has shown over 80 % effectiveness in recurrent C. difficile infection. [3]

4. Exposomes – The Unseen Forces Shaping Your Microbiota
Beyond capsules, the greatest determinant of your microbiota’s success is you – specifically, your exposome.�An exposome encompasses all environmental factors that influence your biological systems – diet, stress, sleep, pollution, medications, and even your social interactions.

Each of these factors can either nurture or disrupt your microbial ecosystem. For instance:
- Antibiotics kill pathogens but also destroy the set ratio of the different strains necessary for optimal operation.
- Processed foods and additives promote dysbiosis, while dietary fibers support microbial diversity.
- Chronic stress and poor sleep directly alter the gut-brain axis, changing microbial composition.

Clinically, gradual correction of diet, sleep, stress and medication load tends to support microbial resilience more reliably than rapid, restrictive regimens; these adjustments also condition the host environment for durable engraftment after FMT [2], [4].
From a clinical standpoint, exposome management is less about radical interventions and more about gradual correction of environmental pressures. Examples include reducing ultra-processed foods, aligning sleep with circadian rhythms and moderating medication use when possible. These changes influence microbial resilience more reliably than sudden, restrictive regimens.

5. How to Use This Guide
This Handbook is designed as a step-by-step roadmap to help you rebuild your internal ecosystem alongside your FMT therapy. Here's how you should use it:
- Implement One Step at a Time: Don’t rush. Each new action (dietary, lifestyle, environmental) should be introduced in 14-day cycles.
- Track Your Progress: Use a calendar or a tracking sheet (on-line Food and Complaint Diary) to monitor daily actions and changes in your well-being.
- Coordinate with Your Physician: This guide complements your clinical treatment. Always follow your doctor’s instructions regarding FMT capsule intake, other medications, and follow-ups.
- Consistency Over Perfection: It’s okay to stumble. Long-term success comes from small, consistent actions, not drastic overhauls.
- Reinforce, Adapt, Evolve: As your microbiota strengthens, so will your body’s capacity to adapt. This guide will show you how to maintain this progress for life.

For clinicians: these steps are intentionally simplified for patients. In practice the same principles apply in clinical follow-up – monitoring changes, introducing interventions gradually and adapting treatment dynamically.

6. Who We Are – The MicroBiome Bank Team
Every success is powered by a dedicated team of professionals:
- Dr. Attila Bezzegh, Medical Director, Physician-Microbiologist�- As head of the MicroBiome Bank laboratory, I ensure the safe implementation of cutting-edge microbiological technologies, guaranteeing the highest quality microbiota transfer services for our partner institutions.
- Dr. Anna Munar, Exposome Specialist - I provide professional support for physicians during FMT procedures to ensure that patients receive their selected donor material under the most appropriate environmental conditions. My focus is on aligning dietary, lifestyle, and environmental factors so that engraftment and long-term microbiota stability are supported as effectively as possible.
- Dr. Gábor Patay, Microbiota Specialist, Physician�- My role is to support clinical colleagues during microbiota transfers with protocols, focusing on distinguishing between treatment-related side effects and unrelated symptoms in daily practice.
- Dr. László Hernold, Commercial Director, Physician�- As an intensive care physician, I bridge communication between hospitals and our laboratory, providing up-to-date insights on FMT, especially in managing Clostridioides difficile infections.
- Dr. Attila Belatiny-Kenéz, Managing Director, Physician�- My responsibility is to align our company’s strategy with the latest research and legal frameworks, ensuring our services are accessible to all European healthcare institutions. I oversee the development of educational resources for clinicians and patients alike.

We don’t merely distribute microbiota capsules. We deliver knowledge, structure, and clinical backup to every institution we work with, ensuring that microbiota transfer becomes a reliable, accessible therapy across Europe. Our approach remains pragmatic: FMT is not a universal solution, but a therapeutic option with defined indications, clear protocols and the need for multidisciplinary integration.

7. A Final Thought – Health is an Ecosystem, Not a Battlefield
The key message of this Handbook is simple but profound:�Health is not the absence of microbes but the presence of balance.

Dysbiosis is not the root of one disease; it is the foundation of many. Microbiota restoration isn’t about eradicating enemies - it’s about rebuilding alliances within your own body.

This is not a promise of cure but a framework for restoring ecological stability. In clinical reality, outcomes vary, and patient-specific factors strongly influence success. The purpose of this handbook is to offer both patients and physicians a structured way to approach this complexity.

With this guide, FMT capsules, and deliberate lifestyle interventions, you are not just treating a disease. You are rebuilding a resilient, self-sustaining internal ecosystem—one microbe, one habit, and one day at a time.

---------
[1] [1] Peery AF, et al. AGA Clinical Practice Guideline on F***l Microbiota–based Therapies in Adults with Recurrent Clostridioides difficile Infection. Gastroenterology. 2024. Available at: https://www.gastrojournal.org/article/S0016-5085(24)00041-6/fulltext
[2] Porcari S, et al. Key determinants of success in f***l microbiota transplantation: from microbiome to clinic. Cell Host & Microbe. 2023;31(5):573–588. Full text: https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(23)00125-7
[3] Karimi M, et al. Safety and efficacy of f***l microbiota transplantation (FMT) in clinical practice: a systematic review and meta-analysis of open-label studies. Frontiers in Immunology. 2024;15:1439176. Full text (Frontiers): https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1439176/full; PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC11464302/
[4] Arora U, Kedia S, Ahuja V. The practice of f***l microbiota transplantation in inflammatory bowel disease: a review. Intestinal Research. 2023;21(1):17–30. Full text: https://irjournal.org/journal/view.php?number=1033; PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC10850701/
[5] Vaughn BP, et al. Increased intestinal microbial diversity following f***l microbiota transplantation for active Crohn’s disease. Inflammatory Bowel Diseases. 2016;22(9):2182–2190. PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC4995064/
[6] Lee WJ. F***l microbiota transplantation: a review of emerging indications and future directions. Frontiers in Microbiology. 2015;6:211. Full text: https://pubmed.ncbi.nlm.nih.gov/25904866/ (links to journal)

25/10/2025

No 9 – Sleep & Microbiota

Emerging science suggested a link between sleep quality and gut microbiota diversity. People with poor sleep tended to have lower levels of Lactobacillus, Bifidobacterium, and Faecalibacterium—the same microbes linked to mental clarity and immune regulation. Animal models showed that disrupting circadian rhythms altered gut microbial composition, which in turn worsened metabolic and ...

Link in the comment

24/10/2025

No 7 – Fiber, Polyphenols, Prebiotics

So, he started blending variety into every plate. Purple sweet potatoes and black lentils, green plantains, red onions, and rainbow chard. He added ground flax to his kefir, chicory root to his tea, and started soaking mung beans overnight for homemade sprouts. He introduced the ‘Dragon’s Kiss’, hot drink based on ginger, garlic, honey, cinnamon...

Link in the comments

23/10/2025

👉 Tudtad, hogy a Clostridioides difficile (C. diff) nem klasszikus értelemben vett fertőzés?

Valójában sok teljesen egészséges ember bélrendszerében is jelen lehet – anélkül, hogy bármilyen tünetet okozna. A gond akkor kezdődik, amikor az antibiotikumok vagy más tényezők felborítják a bél ökoszisztémáját. Ilyenkor megszűnik a természetes kolonizációs rezisztencia, és a C. diff elszaporodhat. Ezért nevezik a szakértők a betegséget inkább fulmináns diszbiózisnak, nem pedig klasszikus fertőzésnek.

🔎 Tudományos háttér és részletek:
- Miért jelenhet meg C. diff egészséges emberekben is?
- Miért okoznak az antibiotikumok gyakran csak átmeneti javulást?
- Miért jobb az FMT/MTT a visszatérő esetekben?

⚠️ Fontos tudni:
Az antibiotikum az egyik fő kockázati tényező a C. diff kialakulásában, mert tovább mélyíti a bélflóra egyensúlyvesztését.

Ezért a visszatérő fertőzések gyakoriak: a szer tünetileg enyhít, de az alapvető egyensúly nem áll helyre.

A mikrobiota-helyreállító kezelések (pl. FMT, MTT) sokkal magasabb arányban vezetnek tartós gyógyuláshoz, mint az antibiotikumok ismételt alkalmazása.

Megfelelő szűréssel és protokollal ezek a terápiák biztonságosak és irányelvek által ajánlottak.

✅ A tanulság: a C. diff nem egy külső fertőzés, amit „elkapsz”, hanem egy állapot, amely akkor válik súlyossá, ha a bélmikrobiota egyensúlya összeomlik. A valódi megoldás a helyreállítás, nem pedig a végtelen antibiotikum-kúrák ismétlése.

🎯 Miért fontos ez mindannyiunknak?
Mert amíg a közgondolkodásban a C. diff egyszerű „fertőzésként” él, addig rengeteg beteg szenved feleslegesen, és újra meg újra visszaesik.

Ezért indítjuk el a C. diff mentes Magyarország 2026 programot, hogy:
- minden érintett megértse a betegség valódi természetét,
- eljusson a bizonyítékokon alapuló kezelés,
- és együtt csökkentsük a felesleges szenvedést és kórházi terheket.

💡 Mit teszünk mi ezért?
📚 Írásokat teszünk közzé több szinten:
– könnyen érthető figyelemfelkeltő tartalmakat;
– egészségügyi dolgozóknak szóló szakmai anyagokat;
– kezelési protokollokat összefoglaló dokumentumokat.
Ezek egyszerre vitaindítók és edukációs eszközök, amelyek segítenek a megelőzésben.

⏱ 72 órán belül biztosítjuk a standardizált FMT eljárást, ha valakinek szüksége van a kezelésre.

🎁 Ingyenes anyagokkal támogatjuk a felépülőket, hogy a bélmikrobiota diverzitása hosszú távon fennmaradjon.

A kezdeményezés tehát a hagyományos megelőzés–kezelés–rehabilitáció tengelyre épül.

👉 Kövesd oldalunkat, oszd meg ezt a posztot, és támogasd, hogy a C. diff mentes Magyarország 2026 üzenete mindenkihez eljusson!

(Figyelem! A poszt leegyszerűsített megfogalmazásban ismerteti a lényeget a szélesebb közönség számára, ugyanakkor a tudományos közösség tagjainak szakmai érdeklődés esetén részletes, hivatkozásokkal alátámasztott összefoglalót tudunk biztosítani.)

23/10/2025

Toxigenic C. difficile frequently colonizes healthy people without disease, so presence ≠ infection. CDI manifests when antibiotics and other insults collapse colonization resistance (i.e., a fulminant dysbiosis with toxin production - there are of course many factors, AB is one of the main ones). That’s why repeated antibiotics often give temporary relief yet drive recurrence, whereas microbiota restoration (FMT or standardized products) delivers markedly higher, guideline-endorsed cure rates in recurrent CDI. With modern screening, FMT has low serious-event rates; probiotics are generally safe too, but even they carry rare risks in high-risk hosts - so we should choose therapies that restore the ecosystem while managing risk rather than doubling down on the dysbiosis that started the problem.

1) Toxigenic C. difficile can be present without disease; symptoms emerge when dysbiosis removes colonization resistance
- Asymptomatic carriage in healthy adults is real (typically 0–15% in healthy cohorts), proving that the organism’s mere presence ≠ disease.
- Pathogenesis depends crucially on ecological disruption (loss of colonization resistance, bile-acid shifts), not a classic “you caught it” exogenous infection model.

2) Antibiotics can suppress symptoms, but the organism (or spores) and perturbed ecology often persist
- After “successful” treatment, patients frequently transition to asymptomatic carriage and continue shedding spores—i.e., microbiota/ecology has not fully normalized. - Recurrence risk tracks with how much antibiotics disrupt the ecosystem; agents that spare the microbiota (e.g., fidaxomicin) reduce recurrence versus broader agents.

3) Antibiotic exposure is a leading, well-proven risk factor for developing CDI
- Large, contemporary studies and systematic reviews consistently identify recent antibiotic use as the dominant modifiable risk.

4) Therefore, if CDI is dysbiosis-driven and antibiotics deepen dysbiosis, antibiotics often give only temporary control; durable recovery depends on ecological restoration
- Reviews integrating microbiota data show that restoring a healthy microbiota is mechanistically aligned with durable remission, whereas repeated antibiotics can perpetuate dysbiosis and recurrence.

5) Microbiota-restoring therapies (FMT and standardized microbiota products) achieve higher cure/recurrence-prevention rates than antibiotics alone—especially in recurrent CDI
- Landmark RCT: FMT beat vancomycin dramatically in recurrent CDI (trial stopped early for efficacy).
- Meta-analysis of RCTs: FMT consistently outperforms antibiotic comparators in rCDI.
- FDA-approved, standardized microbiota therapeutics show significant recurrence reduction after SOC antibiotics (SER-109 oral spores; RBX2660 e***a).

6) When performed with rigorous screening, FMT has low serious-adverse-event (SAE) rates and is guideline-endorsed for recurrent CDI
- Pooled data show SAEs

22/10/2025

It wasn’t hunger that woke him – it was rhythm. He began rising earlier. Not because of discipline or a new alarm, but because his body started syncing with something deeper. He had changed what he ate, but now it was time to change when he ate it. And it began with a simple principle: close the kitchen ...

The Clock That Heals It wasn’t hunger that woke him – it was rhythm. He began rising earlier. Not because of discipline or a new alarm, but because his body started syncing with something deeper. He had changed what he ate, but now it was time to change when he ate it. And it began

17/10/2025

2026-ra ambíciózus célunk van: szeretnénk egy különlegesen veszélyes baktériumot visszaszorítani a hazai kórházakban, amire október 15-től készen állunk.

Célunk, hogy senki ne halhasson meg olyan betegségben Magyarországon, amely elérhető, megfizethető és állami finanszírozásban igény bevehető (lenne).

Célunk, hogy 2026 december 31-ig minden kórházban rendelkezésre álljon a sportolók és egészséges donorok szervezetéből nyert baktérium-koncentráció, melyet a beteg szervezetébe kapszulával tudunk bevinni.

Szerény AI-tudásunk segítségével elkezdtünk gondolkozni azon, hogy milyen egyszerű, mégis kifejező logót válasszunk a kezdeményezésünknek. Ha van ötletetek, mi fejezné ki igazán a célt (Magyarország Clostridium difficile mentessé tételét), segítsetek egy megfelelő emblémát találni/készíteni.

Köszönjük!
Bezzegh-Patay-Belatiny-Hernold

U.I. Az “igénybevehető” egybe irandó…

04/10/2025

Dragon’s Kiss
The recipe originally came from Lee, but he lost me years ago at the spicy chicken wings. Even then, I somehow felt there was a serious gap between our tolerance levels for chili.

Then Tamás invited me for breakfast, and I tried the “Dragon’s Kiss.” The first thing I remember was the strange texture—right after my eyes started watering.
“You don’t have to put in this much chili, but that’s how I usually do it,” he said.

The drink, based mainly on green or chamomile tea, should be consumed pleasantly warm while stirring continuously. When the clove berry reaches your mouth, it’s polite to chew it—and unless you grew up in Felcsút, instead of spitting out the stem, you may leave it neatly on the edge of the plate.

The bold flavor comes from turmeric, pepper, ginger, and garlic extract, softened a bit by cinnamon, clove, lemon juice, and honey. For certain reasons, I leave out the ground cumin, though it is undoubtedly part of the recipe.

The ingredients and recipe were shared in our newsletter.
---------------------------

Sárkány csókja
A recept eredetileg Lee-től származott, de engem a csípős csirkeszárnyaknál évekkel ezelőtt elvesztett. Akkor is valamiért úgy gondoltam, hogy a chili-vel szembeni tűrőképességünk között komoly hiatus áll fenn.

Aztán Tamás meghívott egy reggelire és kipróbáltam a "Sárkány csókját". Az első, amire emlékszem, az a furcsa textúra volt, közvetlenül azután, hogy elkezdett könnyezni a szemem.
- Ennyi chilit nem kell feltétlenül beletenni, de én így szoktam. - mondta.

Az alapvetően zöld- vagy kamillateára épülő italt kellemesen melegen, folyamatos kevergetés közben kell meginni. A szájba kerülő szegfűszeg bogyóját illik szétrágni, és ha nem Felcsúton nőttél fel, akkor szétköpködés helyett a szárat a tányér szélén hagyhatod.

A karakteres ízt a kurkuma, a bors, a gyömbér- és a fokhagyma-kivonat adja, ezen lágyít kicsit a fahéj, a szegfűszeg, a citrom leve és a méz. Az őrölt római köményt én bizonyos okoknál fogva kihagyom, de kétségtelenül a recept részét képezi.
--------------
Az összetevőket és a receptet a hírlevélben küldtük ki.

14/09/2025

Hospital-acquired infections remain a global health challenge, and Clostridioides difficile (C. diff) stands among the most serious. While widely recognized, it is less commonly understood that C. diff requires multiple predisposing factors to manifest: disrupted sleep, poor diet, limited physical activity, and neglect of the microbiota. This dysbiosis provides the conditions for C. diff to colonize and, in severe cases, threaten life itself.

Equally underappreciated is the fact that this condition is not only preventable but also curable. Families need not face unnecessary loss. As Europe’s largest microbiota bank, we view it as our duty to stand by patients until regulatory and political bodies acknowledge that with a single policy decision—cost-neutral and even cost-saving compared to extended hospitalization—countless lives could be spared: mothers, neighbors, colleagues, and our own.

However, curative treatment is only the first stage. It preserves life, but the quality of recovery depends heavily on post-treatment rehabilitation, lifestyle adjustments, and ongoing care of the patient’s microbiota. Without these, the cycle of dysbiosis may repeat.

In response, we are initiating a three-step, three-level program to eliminate C. diff from hospitals by 2026. The pillars are clear:
- Prevention – dissemination of knowledge and strategies to reduce dysbiosis risk.
- Treatment – provision of validated microbiota-based therapies.
- Rehabilitation – structured aftercare to sustain long-term microbiota balance and patient wellbeing.

“Prevention, treatment, aftercare – through the transfer of proper knowledge.”

Our handbook represents the first stage of the program. It consolidates over 11 years of scientific communication, reorganized into a coherent framework. Topics are presented in a neutral, evidence-based tone, supported by modern computational and AI methodologies. The structure emphasizes:
- determinants of microbiota health,
- methods of intervention,
- expected consequences of imbalance, and
- practical recommendations for clinical and patient application.

We recognize that scientific debates around microbiota-based therapies are ongoing. Nevertheless, our aim is not to engage in disputes of priority or origin but to drive measurable clinical impact: saving lives, restoring health through rehabilitation, and preventing recurrence.

We call on the medical community to join us: to share expertise, to co-create educational initiatives for vulnerable populations, and to contribute to a collective effort to eliminate C. diff as a national, and ultimately international, health threat.

October 1st marks the beginning. Together, let us commit to making our hospitals—and our country—free of Clostridioides difficile.

16/08/2025

A Practical Guide to Taking Control of Your Microbiota – Before, During, and After FMT

Over the past few years, we’ve seen a growing wave of interest—and urgent need—for a clear, trustworthy guide to navigating microbiota-based therapies. Patients facing FMT (f***l microbiota transplantation) and doctors supporting them are asking the same essential questions:
What exactly is happening in my body? How can I support the process? What should I do to protect and strengthen my gut microbiota?

In response, we’ve created something unique:
a comprehensive yet easy-to-use Microbiota Manipulation Handbook, tailored specifically for people preparing for FMT, undergoing treatment, or maintaining the results long-term.

This handbook isn’t just another generic health guide. It’s a practical tool—a roadmap—designed to help you understand and influence the powerful ecosystem inside you. Whether you’re a patient looking for clarity and control, or a doctor seeking evidence-based strategies to guide your patients, this handbook was made for you.

To make it useful across borders and cultures, we’re publishing the core content in English—so healthcare providers around the world can adapt it quickly for their own practice. Our version for patients includes clear, accessible explanations of what’s happening in the body during each phase of treatment, how it affects the gut microbiota, and what to do to support healing and long-term success. We’ll also be sharing a simplified version here in a serialized format.

But this is more than a guide—it’s a shift in perspective.
We aim to reframe dysbiosis not as a vague or secondary issue, but as a subclinical condition at the root of many chronic health problems. We explore how conditions like C. difficile infection—often treated as a classic infection—may in fact be the result of a deeper microbial imbalance, and how FMT can help if done with precision and personalization.
Because FMT is not one-size-fits-all. And healing the microbiota requires more than just capsules—it requires understanding, timing, and ongoing care.

Currently spanning 78 chapters and growing every week, this handbook covers a wide range of topics, including:
- Nutrition and key nutrients
- The effects of medications and medical treatments
- Lifestyle choices and circadian rhythms (work, sleep, light exposure)
- Environmental influences and exposomes
- Hygiene, genetics, and even cultural and social habits

If you’re serious about gut health—whether as a patient or practitioner—this is the guide you’ve been waiting for.

04/08/2025

“Would You Swallow That to Live Longer?”He had done strange things before. Fasted for 3 days. Run a 42K with nothing but water and salt on a 400m track. But then he was only 17. Participated in over a hundred f***l transplants. But this was different. This time, the recipient wasn’t sick. This time, the goal wasn’t survival – it was potential...

Click on the link to read on:
https://microbiomebank.com/en/2024/poop-as-medicine-fmt-intro/
----------
„Lenyelnéd, hogy tovább élj?”
Csinált már furcsa dolgokat korábban is. Böjtölt három napig. Lefutott egy maratont (42 km-t) csak vízzel és sóval, egy 400 méteres atlétikai pályán körözve. De akkor még csak 17 volt. Részt vett több mint száz széklettranszplantációnál. De ez most más volt. Most a „páciens” nem volt beteg. Ezúttal a cél nem a túlélés volt – hanem a potenciál...

Kattints a linkre a folytatáshoz:
https://microbiomebank.com/hu/2024/szeklet-mint-orvossag-bevezetes-az-fmt-be/

Lenyelnéd, hogy tovább élj? Csinált már furcsa dolgokat korábban is. Böjtölt három napig. Lefutott egy maratont (42 km-t) csak vízzel és sóval, egy 400 méteres atlétikai pályán körözve. De akkor még csak 17 volt. Részt vett több mint száz széklettranszplantációnál. De ez mo...

01/08/2025

They say knowledge is power. But at 49, sitting at the edge of a trail he once visited as a beginner runner, he wasn’t so sure anymore. He had spent most of his life and career looking for something meaningful that would help others – dozens of patients with mysterious gut illnesses, Autism, even depression – often using a treatment most doctors still find unthinkable: f***l microbiota transplantation (FMT). But his own body? His own vitality? For a long period? Slipping.

Link at the comments
- - - - - - - - - - -
Azt mondják, a tudás hatalom. De 49 évesen, egy erdei ösvény szélén ülve — ahol valaha kezdő futóként járt — már nem volt ebben annyira biztos. Életének és pályafutásának egy jó részét azzal töltötte, hogy valami értelmes tevékenységet találjon, mellyel másokon— tucatnyi, titokzatos bélbetegséggel, autizmussal, sőt depresszióval küzdő páciensnek — segíthet, gyakran olyan kezelést alkalmazva, amit az orvosok többsége ma is elképzelhetetlennek tart: széklet mikrobióta átültetést (FMT). Volt, hogy sikerült másokon segíteni. De a saját teste? A saját vitalitása? Ha hosszú távon nézi? Az kicsúszni látszott a kezei közül.

Folytatás a hozzászólások között (valahol...)

A kezdet: A beleimben érzem Azt mondják, a tudás hatalom. De 49 évesen, egy erdei ösvény szélén ülve — ahol valaha kezdő futóként járt — már nem volt ebben annyira biztos. Életének és pályafutásának egy jó részét azzal töltötte, hogy valami értelmes tevékenységet tal....